Abstract
Introduction
Total hip arthroplasty is a very effective reconstructive surgery but is often associated with massive perioperative bleeding, which leads to anemia. Tranexamic acid (TXA) minimizes bleeding and the need for blood transfusion. However, no universal standard TXA dosing regimen has been established. The objectives of this study were (1) whether there was a difference in the amount of decrease in perioperative mean hemoglobin (Hb) level between a single topical administration of TXA and intravenous and topical combination administration, and we also investigated whether there was a difference in the amount of decrease in the perioperative mean Hb level due to the difference in the local dose of TXA.
Methods
We retrospectively reviewed 292 hips between June 2013 and October 2020. The decrease in Hb level (difference between the preoperative value and the 7-day postoperative value) was used to estimate total perioperative blood loss. The mean perioperative reduction in Hb was compared between hips that received intravenous TXA preoperatively and intra-articular TXA at wound closure (combination administration group) and those that received only intra-articular TXA (single dose group). It was also compared by different local doses of tranexamic acid.
Results
The mean reduction in Hb was significantly smaller in the combination administration group than in the single dose group. However, no significant difference was observed due to the difference in the local dose of TXA administered at the time of wound closure.
Conclusion
Reducing perioperative bleeding decreases the invasiveness of surgery, which is important from the perspective of medical safety.
Similar content being viewed by others
References
Siopack, J. S., & Jergesen, H. E. (1995). Total hip arthroplasty. Western Journal of Medicine, 162(3), 243–249.
Wind, T. C., Barfield, W. R., & Moskal, J. T. (2014). The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplast, 29(2), 387–389.
Zhou, J. (2016). A review of the application of autologous blood transfusion. Brazilian Journal of Medical and Biological Research., 49(9), 5493.
Lin, Z. X., & Woolf, S. K. (2016). Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics, 39(2), 119–130.
Zhou, X. D., Tao, L. J., Li, J., & Wu, L. D. (2013). Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Archives of Orthopaedic and Trauma Surgery, 133, 1017–1027.
Zhang, P., Liang, Y., Chen, P., Fang, Y., He, J., & Wang, J. (2016). Intravenous versus topical tranexamic acid in primary total hip replacement: A meta-analysis. Medicine, 95(50), e5573.
Li, J., Zhang, Z., & Chen, J. (2016). Comparison of efficacy and safety of topical versus intravenous tranexamic acid in total hip arthroplasty: A meta-analysis. Medicine, 95(36), e4689.
Zhu, J., Zhu, Y., Lei, P., Zeng, M., Su, W., & Hu, Y. (2017). Efficacy and safety of tranexamic acid in total hip replacement: A PRISMA-compliant meta-analysis of 25 randomized controlled trials. Medicine, 96(52), e9552.
Chen, S., Wu, K., Kong, G., Feng, W., Deng, Z., & Wang, H. (2016). The efficacy of topical tranexamic acid in total hip arthroplasty: A meta-analysis. BMC Musculoskeletal Disorders, 17, 81.
Hallstrom, B., Singal, B., Cowen, M. E., Roberts, K. C., & Hughes, R. E. (2016). The Michigan experience with safety and effectiveness of tranexamic acid use in hip and knee arthroplasty. The Journal of Bone and Joint Surgery American, 98(19), 1646–1655.
Wei, Z., & Liu, M. (2015). The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: A meta-analysis of 2720 cases. Transfusion Medicine (Oxford, England), 25(3), 151–162.
Okamoto, S., & Okamoto, U. (1962). Amino-methyl-cyclohexane-carboxylic acid: AMCHA; A new potent inhibitor of the fibrinolysisis. Keio Journal of Medicine, 11(3), 105–115.
Shakur-Still, H., Roberts, I., & Fawole, B. (2017). Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. The Lancet, 389(10084), 2105–2116.
Jia, J. (2019). Combined use of intravenous and topical tranexamic acid in patients aged over 70 years old undergoing total hip arthroplasty. Journal of Orthopaedic Surgery and Research, 14(1), 345.
Yi, Z., Bin, S., Jing, Y., Zongke, Z., Pengde, K., & Fuxing, P. (2016). Tranexamic acid administration in primary total hip arthroplasty: A randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. Journal of Bone and Joint Surgery. American Volume, 98(12), 983–991.
Xie, J., Ma, J., Yue, C., Kang, P., & Pei, F. (2016). Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomised clinical trial. Hip International, 26(1), 36–42.
Wu, Y. G., Zeng, Y., Yang, T. M., Si, H. B., Cao, F., & Shen, B. (2016). The efficacy and safety of combination of intravenous and topical tranexamic acid in revision hip arthroplasty: A randomized controlled trial. Journal of Arthroplasty, 31(11), 2548–2553.
Zeng, Y., Si, H. B., Shen, B., Yang, J., Zhou, Z. K., Kang, P. D., & Pei, F. X. (2017). Intravenous combined with topical administration of tranexamic acid in primary total hip arthroplasty: A randomized controlled trial. Orthopeadic Surgery, 9(2), 174–179.
Zhang, H., He, G., Zhang, C., Xu, B., Wang, X., & Zhang, C. (2017). Is combined topical and intravenous tranexamic acid superior to intravenous tranexamic acid alone for controlling blood loss after total hip arthroplasty?: A meta-analysis. Medicine, 96(21), e6916.
Yoon, B. H., Kim, T. Y., Ko, Y. S., Lee, Y. K., Ha, Y. C., & Koo, K. H. (2018). Optimal use of tranexamic acid for total hip arthroplasty: A network meta-analysis. PLoS ONE, 13(10), 1.
Draxler, D. F., & Medcalf, R. L. (2015). The fibrinolytic system—more than fibrinolysis? Transfusion Medicine Reviews, 29(2), 102–109.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests
The authors declare that they have no conflict of interest.
Ethical standard statement
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This research has been approved by the IRB (approval number: 2017-14) of the authors’ affiliated institution.
Rights and permissions
About this article
Cite this article
Nakamura, M., Shimakawa, T., Nakano, S. et al. Effectiveness of Primary Total Hip Arthroplasty Combined with Intra-articular and Intravenous Tranexamic Acid: A Retrospective Analysis of Number of Doses and Dose Strength. JOIO 56, 1234–1239 (2022). https://doi.org/10.1007/s43465-021-00595-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43465-021-00595-z